Exact Sciences Corp (EXAS) - Comprehensive Stock Analysis & Investment Research
Deep dive into Exact Sciences Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.
Exact Sciences Corp Investment Summary
When evaluating whether Exact Sciences Corp (EXAS) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.
Company Profile
Exact Sciences Corp (EXAS) operates within the Industrial Applications and Services sector, specifically in the Services-Medical Laboratories industry. The company employs approximately 5,120 people. With a market capitalization of $20 billion, the company is a large-cap stock offering relative stability combined with growth potential.
Financial Performance Analysis
Our comprehensive financial analysis covers Exact Sciences Corp's revenue, profitability metrics, balance sheet strength, and cash flow generation...
AI Price Predictions
Get AI-powered 7-day, 30-day and 90-day price forecasts for Exact Sciences Corp along with confidence scores and detailed analysis...
Investment Considerations
Expert analysis of whether Exact Sciences Corp is suitable for your investment objectives, risk tolerance, and time horizon...
Corporate Identity
Exact Sciences Corp (Stock Symbol: EXAS) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Services-Medical Laboratories industry. The company's shares are publicly traded on the Nasdaq exchange.
Leadership & Workforce
Detailed information about Exact Sciences Corp's leadership team, workforce size, and organizational structure...
Market Classification
Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Exact Sciences Corp...
Sector & Industry Analysis
In-depth sector dynamics and industry context for Exact Sciences Corp...
Revenue & Growth Analysis
Exact Sciences Corp generates annual revenues of $3 billion , indicating a well-established business with proven market demand.
Profitability Metrics
Net profit margin, gross margin, and operating margin analysis for Exact Sciences Corp...
Market Valuation
P/E ratio, price-to-book, and valuation multiples for Exact Sciences Corp...
Return Metrics
Return on equity (ROE), return on assets (ROA), and capital efficiency for Exact Sciences Corp...
Strategic Market Position
Exact Sciences Corp strategically competes in the highly dynamic Services-Medical Laboratories marketplace. As a large-cap market participant, the company has established significant competitive advantages and market presence. Large-cap companies typically benefit from brand recognition, operational scale, diverse revenue streams, and the financial resources to invest in research and development, marketing, and strategic acquisitions. This size category attracts substantial institutional ownership and analyst coverage.
Industry Competitive Landscape
Exact Sciences Corp competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.
Operational Efficiency
The company currently shows negative free cash flow of $-355 million . Negative free cash flow may reflect heavy investment in growth, working capital needs, or operational challenges. This is common for high-growth companies investing aggressively but warrants attention for mature businesses.
Margin & Pricing Power Analysis
The company maintains a 16027.6% gross margin which reflects exceptional pricing power and/or an asset-light business model. Gross margins at this level are typically seen in software, pharmaceuticals, or luxury goods companies where the cost of incremental production is minimal relative to selling prices. Such margins indicate significant competitive advantages protecting the company from price-based competition.
Operating margin of -23184.7% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.
Asset Utilization Efficiency
Asset turnover ratio of 0.28x indicates lower asset turnover that may reflect the industry's capital-intensive nature or potentially underutilized assets. Companies with low turnover typically depend on strong margins to generate adequate returns on capital.
Financial Strength & Leverage
Current ratio of 2.53 demonstrates strong short-term liquidity with current assets significantly exceeding current liabilities. This provides a substantial buffer for meeting near-term obligations and handling unexpected financial needs.